Diverse effect of WWOX overexpression in HT29 and SW480 colon cancer cell lines

WW-domain-containing oxidoreductase (WWOX) is the tumour suppressor gene from the common fragile site FRA16D, whose altered expression has been observed in tumours of various origins. Its suppressive role and influence on basic cellular processes such as proliferation and apoptosis have been confirmed in many in vitro and in vivo studies. Moreover, its protein is thought to take part in the regulation of tissue morphogenesis and cell differentiation. However, its role in colon cancer formation remains unclear. The aim of this study was to characterize the influence of WWOX on the process of colon cancerogenesis, the basic features of the cancer cell and its expression profiles. Multiple biological tests, microarray experiments and quantitative reverse transcriptase (RT)-PCR were performed on two colon cancer cell lines, HT29 and SW480, which differ in morphology, expression of differentiation markers, migratory characteristics and metastasis potential and which represent negative (HT29) and low (SW480) WWOX expression levels. The cell lines were subjected to retroviral transfection, inducting WWOX overexpression. WWOX was found to have diverse effects on proliferation, apoptosis and the adhesion potential of modified cell lines. Our observations suggest that in the HT29 colon cancer cell line, increased expression of WWOX may result in the transition of cancer cells into a more normal colon epithelium phenotype, while in SW480, WWOX demonstrated well-known tumour suppressor properties. Our results also suggest that WWOX does not behave as classical tumour suppressor gene, and its influence on cell functioning is more global and complicated.

[1]  K. Yanagihara,et al.  Loss of WW domain-containing oxidoreductase expression in the progression and development of gastric carcinoma: clinical and histopathologic correlations , 2010, Virchows Archiv.

[2]  D. Iliopoulos,et al.  A role for the WWOX gene in prostate cancer. , 2006, Cancer research.

[3]  A. Bednarek,et al.  WWOX, a novel WW domain-containing protein mapping to human chromosome 16q23.3-24.1, a region frequently affected in breast cancer. , 2000, Cancer research.

[4]  K. Mimori,et al.  Clinical significance of growth differentiation factor 11 in colorectal cancer. , 2007, International journal of oncology.

[5]  A. Sahin,et al.  Frequent loss of WWOX expression in breast cancer: correlation with estrogen receptor status , 2004, Breast Cancer Research and Treatment.

[6]  J. Ludes-Meyers,et al.  Frequent downregulation and loss of WWOX gene expression in human hepatocellular carcinoma , 2004, British Journal of Cancer.

[7]  R. Aqeilan,et al.  Role of the WWOX gene, encompassing fragile region FRA16D, in suppression of pancreatic carcinoma cells , 2008, Cancer science.

[8]  A. Barbat,et al.  Epithelial polarity, villin expression, and enterocytic differentiation of cultured human colon carcinoma cells: a survey of twenty cell lines. , 1988, Cancer research.

[9]  C. Morrison,et al.  Aberrant expression of DNA damage response proteins is associated with breast cancer subtype and clinical features , 2011, Breast Cancer Research and Treatment.

[10]  G. Horgan,et al.  Relative expression software tool (REST©) for group-wise comparison and statistical analysis of relative expression results in real-time PCR , 2002 .

[11]  J. Heath,et al.  Transforming Growth Factor β1 Signaling via Interaction with Cell Surface Hyal-2 and Recruitment of WWOX/WOX1* , 2009, The Journal of Biological Chemistry.

[12]  M. Nowakowska,et al.  Genetic alterations of WWOX in Wilms' tumor are involved in its carcinogenesis. , 2012, Oncology reports.

[13]  A. Papavassiliou,et al.  TGF-beta signalling in colon carcinogenesis. , 2012, Cancer letters.

[14]  A. Bednarek,et al.  WWOX expression in colorectal cancer—a real-time quantitative RT-PCR study , 2011, Tumor Biology.

[15]  Suet Yi Leung,et al.  Gene expression patterns of human colon tops and basal crypts and BMP antagonists as intestinal stem cell niche factors , 2007, Proceedings of the National Academy of Sciences.

[16]  V. Speirs,et al.  Loss of expression of oestrogen receptor beta in colon cancer and its association with Dukes' staging. , 2005, Oncology reports.

[17]  Y. Pekarsky,et al.  Loss of WWOX Expression in Gastric Carcinoma , 2004, Clinical Cancer Research.

[18]  Y. Pekarsky,et al.  WW domain-containing proteins, WWOX and YAP, compete for interaction with ErbB-4 and modulate its transcriptional function. , 2005, Cancer research.

[19]  J. Rommens,et al.  BRCA2 germline mutations in male breast cancer cases and breast cancer families , 1996, Nature Genetics.

[20]  A. Bednarek,et al.  WWOX, the tumour suppressor gene affected in multiple cancers. , 2009, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[21]  D. Iliopoulos,et al.  Inhibition of Breast Cancer Cell Growth In vitro and In vivo: Effect of Restoration of Wwox Expression , 2007, Clinical Cancer Research.

[22]  A. Llombart‐Bosch,et al.  Low levels of WWOX protein immunoexpression correlate with tumour grade and a less favourable outcome in patients with urinary bladder tumours , 2008, Histopathology.

[23]  J. Zhen,et al.  Aberrant Expression of WWOX Protein in Epithelial Ovarian Cancer: A Clinicopathologic and Immunohistochemical Study , 2012, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[24]  Ahmet Demirkaya,et al.  WWOX gene may contribute to progression of non-small-cell lung cancer (NSCLC) , 2010, Tumor Biology.

[25]  C. Croce,et al.  Association of Wwox with ErbB4 in breast cancer. , 2007, Cancer research.

[26]  A. Jemal,et al.  Cancer statistics, 2013 , 2013, CA: a cancer journal for clinicians.

[27]  G. Maelandsmo,et al.  Twelve colorectal cancer cell lines exhibit highly variable growth and metastatic capacities in an orthotopic model in nude mice. , 2004, European journal of cancer.

[28]  A. Papavassiliou,et al.  Oestrogen receptor beta (ERbeta) is abundantly expressed in normal colonic mucosa, but declines in colon adenocarcinoma paralleling the tumour's dedifferentiation. , 2003, European journal of cancer.

[29]  Stefano Volinia,et al.  The WWOX Tumor Suppressor Is Essential for Postnatal Survival and Normal Bone Metabolism* , 2008, Journal of Biological Chemistry.

[30]  J. Ludes-Meyers,et al.  WWOX protein expression in normal human tissues , 2006, Journal of Molecular Histology.

[31]  M. Loda,et al.  Evaluation of markers for CpG island methylator phenotype (CIMP) in colorectal cancer by a large population-based sample. , 2007, The Journal of molecular diagnostics : JMD.

[32]  S. Ogino,et al.  Molecular classification and correlates in colorectal cancer. , 2008, The Journal of molecular diagnostics : JMD.

[33]  T. Ko,et al.  TGF-β Signaling in Colon Cancer Cells , 2005, World Journal of Surgery.

[34]  D. Amadori,et al.  WWOX gene restoration prevents lung cancer growth in vitro and in vivo , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[35]  G. Mills,et al.  WWOX protein expression varies among ovarian carcinoma histotypes and correlates with less favorable outcome , 2005, BMC Cancer.

[36]  Kjetil Søreide,et al.  Evolving molecular classification by genomic and proteomic biomarkers in colorectal cancer: potential implications for the surgical oncologist. , 2009, Surgical oncology.

[37]  Pascale Anderle,et al.  Defining new criteria for selection of cell-based intestinal models using publicly available databases , 2012, BMC Genomics.

[38]  A. Bednarek,et al.  LABORATORY INVESTIGATION- HUMAN/ANIMAL TISSUE Molecular analysis of WWOX expression correlation , 2022 .

[39]  A. Paige,et al.  WWOX gene expression abolishes ovarian cancer tumorigenicity in vivo and decreases attachment to fibronectin via integrin alpha3. , 2009, Cancer research.

[40]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.

[41]  S. Kameoka,et al.  Gene profile analysis of colorectal cancer cell lines by cDNA macroarray. , 2007, Oncology reports.

[42]  K. Kinzler,et al.  Apoptosis and APC in colorectal tumorigenesis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[43]  A. Bednarek,et al.  WWOX--the FRA16D cancer gene: expression correlation with breast cancer progression and prognosis. , 2006, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[44]  Zehua Wang,et al.  Cloning of WWOX gene and its growth-inhibiting effects on ovarian cancer cells , 2010, Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban.

[45]  J. Jass.  Classification of colorectal cancer based on correlation of clinical, morphological and molecular features , 2007, Histopathology.

[46]  C. Compton,et al.  The Staging of Colorectal Cancer: 2004 and Beyond , 2004, CA: a cancer journal for clinicians.

[47]  C. Croce,et al.  Genetic alterations of the tumor suppressor gene WWOX in esophageal squamous cell carcinoma. , 2002, Cancer research.

[48]  Paul Salama,et al.  Colorectal cancer stem cells , 2009, ANZ journal of surgery.

[49]  T. Ko,et al.  TGF-beta signaling in colon cancer cells. , 2005, World journal of surgery.

[50]  G. Stein,et al.  Targeted ablation of the WW domain-containing oxidoreductase tumor suppressor leads to impaired steroidogenesis. , 2009, Endocrinology.

[51]  C. Croce,et al.  The Tumor Suppressor Gene WWOX at FRA16D Is Involved in Pancreatic Carcinogenesis , 2004, Clinical Cancer Research.

[52]  Zehua Wang 王泽华,et al.  Cloning of WWOX gene and its growth-inhibiting effects on ovarian cancer cells , 2010, Journal of Huazhong University of Science and Technology [Medical Sciences].

[53]  Xian Zhou,et al.  WWOX induces apoptosis and inhibits proliferation of human hepatoma cell line SMMC-7721. , 2012, World journal of gastroenterology.

[54]  R. Lothe,et al.  Genome signatures of colon carcinoma cell lines. , 2004, Cancer genetics and cytogenetics.

[55]  A. Brenner,et al.  WWOX, the FRA16D gene, behaves as a suppressor of tumor growth. , 2001, Cancer research.